The variables comprised hematological malignancy subtypes, age, gender, concurrent hepatitis C infection, liver cirrhosis, hepatocellular carcinoma, diabetes mellitus, allogeneic transplantation recipient, anti-HBs, and anti-HBc. Here, KRT88P is linked to hepatitis C virus infection.